Literature DB >> 3311662

Crohn's disease. New concepts of pathogenesis and current approaches to treatment.

S P James1, W Strober, T C Quinn, S H Danovitch.   

Abstract

One theory of the pathogenesis of Crohn's disease is that rather than being caused by a unique environmental agent, it is the result of an abnormal immune response in the gastrointestinal tract. Recent studies indicate that Crohn's disease in its early stages is frequently associated with the presence of circulating antigen-non-specific suppressor T cells. Such T cells are also found in experimental inflammation caused by Chlamydia organisms in the gastrointestinal tract of nonhuman primates. Taken together, these data suggest that the suppressor T cells are markers of an underlying and persistent, antigen-specific immune response to an as yet unidentified antigen or set of antigens. We postulate that this underlying antigen-specific response is the result of a primary immunoregulatory abnormality involving an imbalance between the effects of antigen-specific helper and suppressor T cells which recognize a common antigen or antigens present in the mucosal environment.

Entities:  

Mesh:

Year:  1987        PMID: 3311662     DOI: 10.1007/BF01296381

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  31 in total

1.  Comparative mapping of the local distribution of immunoglobulin-containing cells in ulcerative colitis and Crohn's disease of the colon.

Authors:  K Baklien; P Brandtzaeg
Journal:  Clin Exp Immunol       Date:  1975-11       Impact factor: 4.330

2.  Gut mucosal lymphocytes in inflammatory bowel disease: isolation and preliminary functional characterization.

Authors:  C Fiocchi; J R Battisto; R G Farmer
Journal:  Dig Dis Sci       Date:  1979-09       Impact factor: 3.199

3.  Immunoregulatory function of lamina propria T cells in Crohn's disease.

Authors:  S P James; C Fiocchi; A S Graeff; W Strober
Journal:  Gastroenterology       Date:  1985-05       Impact factor: 22.682

4.  Chlamydia, cytomegalovirus, and Yersinia in inflammatory bowel disease.

Authors:  E T Swarbrick; J G Kingham; H L Price; A J Blackshaw; P D Griffiths; S Darougar; N A Buckell
Journal:  Lancet       Date:  1979-07-07       Impact factor: 79.321

5.  Lipopolysaccharide (LPS) regulation of the immune response: LPS influence on oral tolerance induction.

Authors:  S M Michalek; H Kiyono; M J Wannemuehler; L M Mosteller; J R McGhee
Journal:  J Immunol       Date:  1982-05       Impact factor: 5.422

6.  Secretory component-dependent hepatic transport of IgA antibody-antigen complexes.

Authors:  D J Socken; E S Simms; B R Nagy; M M Fisher; B J Underdown
Journal:  J Immunol       Date:  1981-07       Impact factor: 5.422

7.  The effect of antigen on the development of Peyer's patches in sheep.

Authors:  J D Reynolds; B Morris
Journal:  Eur J Immunol       Date:  1984-01       Impact factor: 5.532

8.  Lack of evidence for an association between infection with Chlamydia trachomatis and Crohn's disease, as indicated by micro-immunofluorescence antibody tests.

Authors:  P A Mårdh; B Ursing; E Sandgren
Journal:  Acta Pathol Microbiol Scand B       Date:  1980-02

9.  Suppression of immunoglobulin synthesis by lymphocyte subpopulations in patients with Crohn's disease.

Authors:  S P James; L M Neckers; A S Graeff; J Cossman; C M Balch; W Strober
Journal:  Gastroenterology       Date:  1984-06       Impact factor: 22.682

10.  Chlamydia trachomatis proctitis.

Authors:  T C Quinn; S E Goodell; E Mkrtichian; M D Schuffler; S P Wang; W E Stamm; K K Holmes
Journal:  N Engl J Med       Date:  1981-07-23       Impact factor: 91.245

View more
  9 in total

1.  Impaired mitogenic response of peripheral blood T cells in ulcerative colitis is not due to apoptosis.

Authors:  M A Pérez-Machado; L M Espinosa; E J de la Madrigal; L Abreu; G M Lorente; M Alvarez-Mon
Journal:  Dig Dis Sci       Date:  1999-12       Impact factor: 3.199

2.  The CD8+ Leu-7+ subset of T cells in Crohn's disease: distinction between cytotoxic and covert suppressor functions.

Authors:  R L Deem; S R Targan; A Niederlehner; F Shanahan
Journal:  Clin Exp Immunol       Date:  1990-06       Impact factor: 4.330

Review 3.  Immunosuppressive drugs in inflammatory bowel disease. A review of their mechanisms of efficacy and place in therapy.

Authors:  A B Hawthorne; C J Hawkey
Journal:  Drugs       Date:  1989-08       Impact factor: 9.546

4.  Diminished cytochrome b content and toxic oxygen metabolite production in circulating neutrophils from patients with Crohn's disease.

Authors:  J A Solis-Herruzo; B Fernandez; E Vilalta-Castell; M T Muñoz-Yagüe; I Hernandez-Muñoz; M P de la Torre-Merino; J Balsinde
Journal:  Dig Dis Sci       Date:  1993-09       Impact factor: 3.199

5.  Controlled trial of antimycobacterial therapy in Crohn's disease. Clofazimine versus placebo.

Authors:  N H Afdhal; A Long; J Lennon; J Crowe; D P O'Donoghue
Journal:  Dig Dis Sci       Date:  1991-04       Impact factor: 3.199

6.  Selective expansion of specific T cell receptors in the inflamed colon of Crohn's disease.

Authors:  B Gulwani-Akolkar; P N Akolkar; A Minassian; R Pergolizzi; M McKinley; G Mullin; S Fisher; J Silver
Journal:  J Clin Invest       Date:  1996-09-15       Impact factor: 14.808

7.  Cyclosporin A treatment in inflammatory bowel disease.

Authors:  E F Stange; W E Fleig; E Rehklau; H Ditschuneit
Journal:  Dig Dis Sci       Date:  1989-09       Impact factor: 3.199

8.  Comparison of leukocyte excretion and blood loss in inflammatory disease of the bowel.

Authors:  K Teahon; I Bjarnason
Journal:  Gut       Date:  1993-11       Impact factor: 23.059

9.  Chlamydia trachomatis and inflammatory bowel disease--a coincidence?

Authors:  R Orda; Z Samra; Y Levy; Y Shperber; E Scapa
Journal:  J R Soc Med       Date:  1990-01       Impact factor: 18.000

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.